(Q43852686)

27 November 2017

title

5-Lipoxygenase and human pulmonary artery endothelial cell proliferation (English)

1 reference

27 November 2017

0 references

2

Joseph Loscalzo

1 reference

27 November 2017

Jennifer L Walker

1

1 reference

27 November 2017

Ying-Yi Zhang

series ordinal

3

1 reference

27 November 2017

language of work or name

1 reference

1 February 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

27 November 2017

published in

1 reference

27 November 2017

volume

282

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

H585-93

1 reference

5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Lipoxygenase inhibitors block PDGF-induced mitogenesis: a MAPK-independent mechanism that blocks fos and egr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Effects of two novel inhibitors of 5-lipoxygenase, L-651,392 and L-651,896, in a guinea-pig model of epidermal hyperproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Inhibition of tumour growth by lipoxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

5-lipoxygenase-activating protein is an arachidonate binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene C4 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Interaction of 5-lipoxygenase with cellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Influence of 5-lipoxygenase on in vitro growth of human mammary carcinoma cell line MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

Identification and isolation of a membrane protein necessary for leukotriene production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00003.2001

10.1152/AJPHEART.00003.2001

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference